Candela Laser v. Cynosure
This article was originally published in The Gray Sheet
Executive Summary
U.S. District Court for the District of Massachusetts rules that Cynosure's Photo-Genica V laser does not infringe Candela's 5,066,293 patent, which covers a method for treating cutaneous vascular lesions, Candela announces March 22. The court has not yet ruled on Candela's claim of infringement of its 5,109,387 patent covering a laser dye circulation system. The firm says it initiated the action based on its belief of infringement of the "293 patent and that it will consider appeal after review of the court's written decision